Skin cancer risk in alopecia areata: a systematic review and meta-analysis - Top-Institutions - MDSpire

Skin cancer risk in alopecia areata: a systematic review and meta-analysis

  • By

  • Simonetta I. Gaumond

  • Alireza Abdshah

  • Isabella Kamholtz

  • Peyton V. Warp

  • Keyvan Nouri

  • Antonella Tosti

  • Joaquin J. Jimenez

  • May 11, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Yale School of Medicine/Yale New Haven Hospital
    Yale School of Medicine/Yale New Haven Hospital

    New Haven, Connecticut

    Key Differentiators

    • Dermatology
    • Oncology

  • #2

    Columbia University Irving Medical Center/NewYork-Presbyterian Hospital
    Columbia University Irving Medical Center/NewYork-Presbyterian Hospital

    New York, New York

    Key Differentiators

    • Dermatology
    • Oncology

  • #3

    National Cancer Institute
    National Cancer Institute

    Bethesda, Maryland

    Key Differentiators

    • Oncology
    • Dermatology

  • #4

    German Cancer Research Center
    German Cancer Research Center

    Heidelberg, Germany

    Key Differentiators

    • Oncology
    • Dermatology

  • #5

    University of Gothenburg
    University of Gothenburg

    Gothenburg, Sweden

    Key Differentiators

    • Dermatology

Original Source(s)

Skin cancer risk in alopecia areata: a systematic review and meta-analysis

  • by Simonetta I. Gaumond, Alireza Abdshah, Isabella Kamholtz, Peyton V. Warp, Keyvan Nouri, Antonella Tosti, Joaquin J. Jimenez

  • May 11, 2026

Related Content

Case Report: First description of an intracranial “NET” in ROHHAD syndrome; time to rename to the ROHHAD-NeCT syndrome?

Recurrent pleuropulmonary blastoma type III initially misclassified as embryonal rhabdomyosarcoma on limited biopsy: a case report with pathogenic DICER1 variant

Beyond inhibition: harnessing the DRD2–VEGF-A feedback loop for precision anti-angiogenesis therapy in cancer